Decitabine in Treating Patients With Melanoma or Other Advanced Cancer
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so
they stop growing or die.
PURPOSE: Phase I trial to study the effectiveness of decitabine in treating patients with
stage III or stage IV melanoma or other advanced cancer that has not responded to previous
therapy.